SCHEMBL15902136

SCHEMBL15902136

O=Cc1cn(C(=O)O)c2c(Cl)cccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
KMT2A Q03164 5/20 0.39
MEN1 O00255 4/20 0.39
RORC P51449 4/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TDP1 Q9NUW8 1/20 0.36
PARP1 P09874 1/20 0.36
IMPDH2 P12268 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.35
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
NOTUM Q6P988 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
POLB P06746 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
HSP90AA1 P07900 1/20 0.33
IDO1 P14902 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14832849 0.81 TRIM24 (0.41) ALDH1A1KMT2AMEN1RORCTDP1
SCHEMBL15902591 0.81 ERN1 (0.42) ALDH1A1KMT2AMEN1RORCHTT
SCHEMBL15902489 0.79 ACHE (0.39) ALDH1A1KMT2AMEN1RORCHTT
SCHEMBL15902247 0.78 ERN1 (0.46) ALDH1A1KMT2AMEN1RORCHTT
SCHEMBL838056 0.76 ALDH1A1 (0.54) ALDH1A1KMT2AMEN1HTTSMN1; SMN2
SCHEMBL15901985 0.75 ALDH1A1 (0.36) ALDH1A1KMT2AMEN1RORCHTT
SCHEMBL5736785 0.73 ALDH1A1 (0.56) ALDH1A1KMT2AMEN1HTTSMN1; SMN2
SCHEMBL30234384 0.73 ALDH1A1 (0.56) ALDH1A1KMT2AMEN1HTTSMN1; SMN2
SCHEMBL14689705 0.73 ALDH1A1 (0.40) ALDH1A1KMT2AMEN1HTTSMN1; SMN2
SCHEMBL17829640 0.73 ALDH1A1 (0.52) ALDH1A1KMT2AMEN1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12012411-B2 Viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2024-06-18 US disclosed
EP-3617192-A1 VIRAL REPLICATION INHIBITORS Katholieke Universiteit Leuven K.U. Leuven R&D (BE) 2020-03-04 EP disclosed
US-10550123-B2 Viral replication inhibitors KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2020-02-04 US disclosed
US-20190337954-A1 VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2019-11-07 US disclosed
EP-2760831-B1 VIRAL REPLICATION INHIBITORS UNIV LEUVEN KATH (BE) 2019-08-07 EP disclosed
US-20140213586-A1 VIRAL REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2014-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140213586-A1 VIRAL REPLICATION INHIBITORS EIF2AK2, MAVS, ZC3HAV1 ALDH1A1 4277/4885KMT2A 2425/4885MEN1 3390/4885
US-20190337954-A1 VIRAL REPLICATION INHIBITORS EIF2AK2, MAVS, ZC3HAV1 ALDH1A1 4277/4885KMT2A 2425/4885MEN1 3390/4885
US-10550123-B2 Viral replication inhibitors EIF2AK2, MAVS, ZC3HAV1 ALDH1A1 4277/4885KMT2A 2425/4885MEN1 3390/4885
US-12012411-B2 Viral replication inhibitors EIF2AK2, MAVS, ZC3HAV1 ALDH1A1 4277/4885KMT2A 2425/4885MEN1 3390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.